维普中文期刊产品整合服务
64篇 您的检索式:作者名="Merrill JT"
    题名 作者 年代 出处 被引量
1Diagnosis of metaastatic breast cancer to an in-traabdominal lymph node by endoscopic ultrasound 显示文摘Merrill JT 0h YS 2011Case RepGastroenterol2011,5,1:1
2Treatment of systemic lupus erythenmtosus by inhibition of T cell costimulation with anti -CD 154 : a randomized, double-blind, placebo- controlled trial 显示文摘Kalunian KC Davis JC Jr Merrill JT 2002Arthritis Rheum2002,46,12:1
3Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus:the randomized,double-blind,phaseⅡ/Ⅲsystemic lupus erythematosus evaluation of rituximab trial显示文摘Merrill JT Neuwelt CM Wallace DJ 2010Arthritis Rheum2010,62,1:1
4Challenges in bringing the bench to bedside in drug development for SLE显示文摘Merrill JT Erkan D Buyon JP 2004Drug Dis2004,3,:1
5Effccts of belimumab,a B lymphocyte stimulator-specific inhibitor,on disease activity across multiplc organ domains in patients with systemic lupus crythematosus:combined results from two phase Ⅲ trials显示文摘Manzi S Sánchez-Gucrrcro J Merrill JT 0,,11:1
6Treatment ofsystemic lupus erythematosus by inhibition of T cellcostimulation with anti-CD^L: a randomized, double-blind,placebo-controlled trial 显示文摘Kalunian KC Davis JC Merrill JT 2002Arthritis Rheum2002,46,:1
7Treatment of systemic lupus erythematosus: a 2012update显示文摘Merrill JT 2012Bull NYU Hosp Jt Dis2012,70,3:1
8Frequency of antibodies to the cholesterol transport protein:apolipoprotein A1 in patients with SLE显示文摘Dinu AR Merrill JT Shen C 1998Lupus1998,7,5:1
9Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti - CD154: a randomized, double - blind, placebo - controlled trial 显示文摘Kalunian KC Davis JC Merrill JT 2002Arthtitis Rheum2002,46,12:1
10A Phase 1I study of the efficacy and safety of rontalizumab (rhuMAb interferon-) in patients with systemic lupus erythematosus (ROSE)显示文摘Kalunian KC Merrill JT Maciuca R 2016Ann Rheum Dis2016,76,1:1
11Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus:the randomized,double-blind,phase Ⅱ/Ⅲ systemic lupus erythematosus evaluation of rituximab trial显示文摘Merrill JT Neuwelt CM Wallace DJ 0,,01:1
12Belimumab( fully human monoclonal antibody to B-lymphocyte stimulator ) improves or stabilizes SLE activity in a multicenter phase 2 trial显示文摘FURIE R LISSE J MERRILL JT 2006Arthritis Rheum2006,54,1:1
13Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti CD154: a randomized, double-blind, placebo controlled trial 显示文摘Kalunian KC Davis JC Jr Merrill JT 2002Arthritis Rheum2002,46,12:1
14Diagnosis of metastatic breast cancer to an intraabdominal lymph node by endoscopic ultrasound显示文摘Merrill JT Oh YS 0,,01:1
15Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythema- tosus : the randomized, double-blind, phase Ⅱ / Ⅲ systemic lupus erythematosus evaluation of rituximab trial 显示文摘Merrill JT NeuwelCM Wallace DJ 2010Arthritis Rheum2010,62,1:1
16Treatment of systemic lupus erythematosus:new therapeutic avenues and blind alleys显示文摘Thanou A Merrill JT 2014Nat Rev Rheumatol2014,10,1:1
17Safety profile and clinical activity of sifalimumab,a fully human anti-interferon {alpha} monoclonal antibody,in systemic lupus erythematosus:a phase I,multicentre,double-blind randomised study显示文摘Merrill JT Wallace DJ Petri M 0,,11:1
18A highlight from the LUPUS2014 meeting : eight great ideas 显示文摘Buyon JP Cohen P Merrill JT 2015Lupus Sci Med2015,302,00:1
19Safety profile and clinical activity of sifalimumab,a fully human anti-interferon α monoclonal antibody,in systemic lupus erythematosus:a phase I,multicentre,double-blind randomised study显示文摘Merrill JT Wallace DJ Petri M 2011Ann Rheum Dis2011,70,11:1
20Co-stimulatory molecules as targets for treatment of lupus显示文摘Merrill JT 2013Clin Immuno12013,148,3:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费